Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Novo Nordisk shares post the biggest monthly decline since 2002

Novo Nordisk’s stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several disappointing trial results. However, analysts remain optimistic about the shares, forecasting a potential price upside of up to 60% over the next 12 months.

European committee says Lilly Alzheimer's drug shouldn't get marketing approval

European committee says Lilly Alzheimer's drug shouldn't get marketing approval

A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially dangerous risks of brain bleeding and swelling

The Independent UK

EU regulators block new Alzheimer’s drug citing potentially fatal side effects

EU regulators block new Alzheimer’s drug citing potentially fatal side effects

The company behind the drug donanemab said it will ask regulators to reconsider the decision.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Tariff treatment: Six diagnoses for EU pharma sector amid US trade war

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as both the US and Europe heavily rely on each other.

Price Targets Show These 3 Stocks Near the $1 Trillion Mark

See what analysts' price targets say about the prospects of these three stocks flirting with the $1 trillion valuation mark.

How Diabetes Patients Are Fighting for Affordable Insulin

The World Health Organization states that there were around 830 million people living with diabetes in 2022. More than half of them weren't taking diabetes medications, including insulin, likely due to access and cost issues.

Eli Lilly Earns Relative Strength Rating Upgrade

Eli Lilly shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Eli Lilly Shows Rising Relative Price Performance; Still Shy Of Key Threshold

Eli Lilly Shows Rising Relative Price Performance; Still Shy Of Key Threshold

A Relative Strength Rating upgrade for Eli Lilly shows improving technical performance. Will it continue?

Investors Business Daily

Is Amgen Stock a Buy, Sell, or Hold as Weight-Loss Drug Trials Kick Off?

Is Amgen Stock a Buy, Sell, or Hold as Weight-Loss Drug Trials Kick Off?

Amgen is hoping to rival Novo Nordisk and Eli Lilly in the weight-loss drug market.

Novo Nordisk Dives 9%. Why Eli Lilly Now Has The Upper Hand.

Novo Nordisk Dives 9%. Why Eli Lilly Now Has The Upper Hand.

Novo Nordisk stock tumbled Monday after its experimental weight-loss drug failed to top its rival from Eli Lilly in a Phase 3 study.

Investors Business Daily

Dow Jones Dives 890 Points On Trump Comments; Apple, Nvidia, Tesla Sell Off

Dow Jones Dives 890 Points On Trump Comments; Apple, Nvidia, Tesla Sell Off

The Dow Jones tumbled 890 points Monday after President Trump declined to rule out a recession. Apple, Nvidia and Tesla sold off.

Investors Business Daily

Dow Jones Falls On Surprise Jobs Report, Powell Speech Next; Nvidia Partner Crashes On Earnings

Dow Jones Falls On Surprise Jobs Report, Powell Speech Next; Nvidia Partner Crashes On Earnings

The Dow Jones dropped Friday on a surprise jobs report. Fed Chair Powell's speech looms. Nvidia partner Hewlett Packard crashed on earnings.

Investors Business Daily

In Rotten Market, Top Funds Harvest Apple Stock — And 10 Others

In Rotten Market, Top Funds Harvest Apple Stock — And 10 Others

The best mutual funds bet big on Apple stock, Meta, Robinhood, Walmart and seven others while Nasdaq turns bearish.

Investors Business Daily

Eli Lilly Pours $27B Into U.S. Growth—What It Means for Investors

Eli Lilly Pours $27B Into U.S. Growth—What It Means for Investors

Pharma giant Eli Lilly announced plans to make a massive investment in the United States. What does this and another big announcement mean for Lilly?

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stock Market Today: Dow Jones, Other Indexes Pare Losses On Shift In Tariffs (Live Coverage)

The Dow Jones tumbled 600 points as tariff woes resurfaced. Nvidia stock and Tesla sold off on the stock market today.

The Independent UK

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly

Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance

Investors Business Daily

Dow Jones Falls On Surprise Jobs Data; CrowdStrike Plunges On Earnings

The Dow Jones fell Wednesday following surprise jobs data and President Trump's speech to Congress. CrowdStrike plunged on earnings.

Investors Business Daily

It's Not Time To Buy. But These Stocks Flash 'Watch Me' Signs.

As the market turmoil deepens, here are two telltale indicators to track as investors adjust their lists of stocks to watch.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Meta, Netflix Hold Tough As Tech Tanks. This Biotech Booms.

While Netflix and Meta stock fight to shake off market volatility, Eli Lilly and this biotech stock join them and others on IBD Leaderboard.

Is Johnson & Johnson Stock Underperforming the Dow?

Despite Johnson & Johnson’s underperformance relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Is Eli Lilly Stock Outperforming the Nasdaq?

Eli Lilly has outperformed the Nasdaq over the past year, and analysts are highly optimistic about the stock’s prospects.

Investors Business Daily

How To Buy And Sell Stocks: This Table Finds Important Stock Moves

How To Buy And Sell Stocks: Use this IBD table to find stocks that are moving up and down in heavy volume on the stock market today.

Is This Penny Stock’s 525% Upside Potential an Attainable Goal?

Skye Bioscience is trying to establish a presence in the weight-loss drug market.

3 Pharmaceutical Stocks Betting Big on Weight Loss Drugs

Weight-loss drugs aren’t just slimming waists; they create a $100 billion market opportunity. With plenty up for grabs, pharmaceutical giants like Eli Lilly and Company (LLY), Novo Nordisk (NVO), and Amgen (AMGN) are betting big on next-generation weight loss treatments to dominate this booming market. Keeping reading.

Investors Business Daily

Eli Lilly Joins Rank Of Stocks With 95-Plus Composite Rating

Eli Lilly saw its IBD SmartSelect Composite Rating jump to 96 Tuesday, up from 94 the day before.

People

119,526 stories

Micheál Martin

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the European Commission

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

276,709 stories

The United States

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play